EUVIMEDEUVIMED entdecken
Crossref

Branched-Chain Amino Acids Exacerbate Colitis Progression by Lowering Colonic Fumarate Levels

Ana Mendes-Frias iD, Maria C Vieira, Marta Araújo, Cláudio Duarte-Oliveira, Simon Feys iD, Consuelo Micheli, Joana Gaifem, Luís Gafeira Gonçalves, Nuno S Osório, Adhemar Longatto-Filho, António Gil Castro, Egídio Torrado und 6 weitere

Inflammatory Bowel Diseases · 2025

DOI: 10.1093/ibd/izaf125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Ana Mendes-Frias und 17 weiteren Autor:innen. Beteiligte Einrichtung: Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal. Hauptthemen laut MEDLINE: Amino Acids, Branched-Chain, Dimethyl Fumarate, Colitis, Colon. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: FCT/MCTES.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ulcerative colitis (UC) is a gastrointestinal inflammatory condition with an unclear etiology. Recent findings suggest that metabolites play a pivotal role in promoting intestinal health. We have previously observed a significant enrichment in colonic branched-chain amino acids (BCAAs) in resistant mice to colitis suggesting the potential role of these metabolites in UC development.

Methods

C57BL6/J mice underwent a 20-day BCAA supplementation regimen, followed by induction of colitis using dextran sulfate sodium (DSS). Disease activity index (DAI), immune cell profiling, and histological and transcriptomic analysis were evaluated. 16S rRNA sequencing and metabolomic profiling of stool extracts were performed. Additionally, mice were treated with dimethyl fumarate (DMF) post-supplementation to explore therapeutic interventions.

Results

BCAA supplementation exacerbated colitis severity in mice, as evidenced by worsened DAI, increased histological damage, and significant alterations in immune cell populations, including decreased type 3 innate lymphoid cells and increased Th17 and regulatory T cells. Microbiota analysis showed a shift toward a decreased abundance of Lactobacillus spp. and an increase in pathobionts. Metabolomic profiling indicated significantly reduced colonic fumarate levels and increased pro-inflammatory metabolites. DMF treatment attenuated BCAA-induced pro-inflammatory phenotype, improved disease outcomes, and modulated the immune response in a microbiome-dependent manner.

Conclusions

BCAA supplementation exacerbates DSS-induced colitis in mice. This effect is mediated by detrimental changes in gut microbiota composition and metabolome. DMF treatment shows promise to mitigate these adverse effects, suggesting potential therapeutic avenues to manage BCAA-induced colitis exacerbation and reinforcing the role of microbiome in UC. These findings underscore the caution needed with the use of BCAAs during inflammatory conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amino Acids, Branched-ChainDimethyl FumarateColitisColonFumaratesColitis, UlcerativeAnimalsMiceMice, Inbred C57BLDextran SulfateGastrointestinal MicrobiomeDisease ProgressionDisease Models, AnimalMaleMetabolomicsDietary Supplements

Stichwörter der Autor:innen

branched-chain amino acidsfumarateulcerative colitis

Substanzen

Amino Acids, Branched-ChainDextran SulfateDimethyl FumarateFumarates

Autor:innen und Institutionen

  • Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
  • ICVS/3B's-PT Government Associate Laboratory, Braga, Guimarães, Portugal.
  • Medical Intensive Care Unit, Department of General Internal Medicine, University Hospitals Leuven, Leuven, Belgium.
  • Laboratory of Clinical Infectious and Inflammatory Disorders, Department of Microbiology, Immunology, and Transplantation, KU Leuven, Leuven, Belgium.
  • i3S-Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
  • Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, 2780-157 Oeiras, Portugal.

ORCID-Profile: Ana Mendes-Frias, Simon Feys, Agostinho Carvalho, Iola F Duarte, Ricardo Silvestre

Förderung

  • FCT/MCTES

Zitieren

APA

Mendes-Frias, A., Vieira, M. C., Araújo, M., Duarte-Oliveira, C., Feys, S., Micheli, C., Gaifem, J., Gonçalves, L. G., Osório, N. S., Longatto-Filho, A., Castro, A. G., Torrado, E., Cunha, C., Carvalho, A., Duarte, I. F., Silva, N. A., Rodrigues, F., & Silvestre, R. (2025). Branched-Chain Amino Acids Exacerbate Colitis Progression by Lowering Colonic Fumarate Levels. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izaf125

Vancouver

Mendes-Frias A, Vieira MC, Araújo M, Duarte-Oliveira C, Feys S, Micheli C, et al. Branched-Chain Amino Acids Exacerbate Colitis Progression by Lowering Colonic Fumarate Levels. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izaf125

BibTeX
@article{MendesFrias2025,
  author = {Mendes-Frias, Ana and Vieira, Maria C and Araújo, Marta and Duarte-Oliveira, Cláudio and Feys, Simon and Micheli, Consuelo and Gaifem, Joana and Gonçalves, Luís Gafeira and Osório, Nuno S and Longatto-Filho, Adhemar and Castro, António Gil and Torrado, Egídio and Cunha, Cristina and Carvalho, Agostinho and Duarte, Iola F and Silva, Nuno A and Rodrigues, Fernando and Silvestre, Ricardo},
  title = {Branched-Chain Amino Acids Exacerbate Colitis Progression by Lowering Colonic Fumarate Levels},
  journal = {Inflammatory Bowel Diseases},
  year = {2025},
  doi = {10.1093/ibd/izaf125}
}
Kostenlos starten →